Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-17

Clinical Trial Update: Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer [NA]

View source ↗

Summary

Clinical trial investigating fluorine F-18 sodium fluoride PET/CT and whole-body and axial MRI to detect metastases in recurrent prostate cancer has completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluorine F-18 sodium fluoride (fluorine-18 sodium fluoride)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Recurrent Prostate Cancer | NA | Status: COMPLETED | Results posted: 2020-09-17